Seres Therapeutics

Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases.
Type
Public
HQ
Cambridge, US
Founded
2010
Size (employees)
86 (est)
Seres Therapeutics was founded in 2010 and is headquartered in Cambridge, US

Seres Therapeutics Office Locations

Seres Therapeutics has an office in Cambridge
Cambridge, US (HQ)
200 Sidney St

Seres Therapeutics Data and Metrics

Seres Therapeutics Financial Metrics

USD

Market capitalization (21-Sep-2017)

677.4 m
Seres Therapeutics's current market capitalization is $677.4 m.
Show all financial metrics

Seres Therapeutics Market Value History

Seres Therapeutics Job Categories

Traffic Overview of Seres Therapeutics

Seres Therapeutics Online and Social Media Presence

Seres Therapeutics News and Updates

A Promising Poop Pill Just Flunked Clinical Trials

An artist's rendering of poop pills. So close, yet so far. Marc Bruxelle / Getty Images Seres Therapeutics, a pioneer in the race to develop therapeutic pills from poop, has suffered a key setback with a drug failing to pass clinical trials.The results co…

Seres Therapeutics Company Life and Culture

You may also be interested in